Mr Nimish Shah

Qualifications

MBBS, BSc, FRCS (Urol), MS

GMC number: 3666157

Practising since: 1992

Specialties

Urology

Consultation times

  • Weekly Monday 08:00 - 13:00
  • Overview
Book online today Enquire now

Or call us on

Secretary: 0800 756 7771 Appointments: 01223 370922

About

Mr Shah is a Consultant Urologist with specialist interest in:

  • Urinary tract calculi
  • Endourology
  • Laser treatment for stones
  • Lithotripsy
  • Robotic prostatectomy
  • Urology
  • Urological cancers
  • Bladder / kidney stone disease
  • Urinary tract infections
  • Benign prostate diseases
  • Sexual dysfunction
  • Bladder cancer
  • Urological pathology
  • Prostate cancer
  • Erectile dysfunction
  • Andrology

Other interests

  • Men's health issues
  • Benign prostate

Treatments and tests offered by Mr Nimish Shah at Nuffield Health

  • Prostate screening
  • Radical prostatectomy

Locations Mr Nimish Shah works with

  •  

    4 Trumpington Road, Cambridge, CB2 8AF

    01223 370 922
    Overall rating
    Outstanding
     
    View details

Related experience

Research

Recent publications:

Miah S, Maw J, Pang K, Nair V, Hori S, Lamb A, et al. The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care provision. Urol Ann 2022;14:156-61.

Caglic I, Sushentsev N, Colarieti A, Warren AY, Shah N, Lamb BW, Barrett T. Value of the capsular enhancement sign on dynamic contrast-enhanced prostate multiparametric MRI for the detection of extracapsular extension. Eur J Radiol. 2022 May;150:110275. doi: 10.1016/j.ejrad.2022.110275. Epub 2022 Mar 25. PMID: 35358786

Sushentsev N, McLean MA, Warren AY, Benjamin AJV, Brodie C, Frary A, Gill AB, Jones J, Kaggie JD, Lamb BW, Locke MJ, Miller JL, Mills IG, Priest AN, Robb FJL, Shah N, Schulte RF, Graves MJ, Gnanapragasam VJ, Brindle KM, Barrett T, Gallagher FA. Author Correction: Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer. Nat Commun. 2022 Mar 7;13(1):1274. doi: 10.1038/s41467-022-28979-1. PMID: 35256616 Free PMC article.

Caglic I, Sushentsev N, Shah N, Warren AY, Lamb BW, Barrett T. Integration of Prostate Biopsy Results with Pre-Biopsy Multiparametric Magnetic Resonance Imaging Findings Improves Local Staging of Prostate Cancer. Can Assoc Radiol J. 2022 Feb 24:8465371211073158. doi: 10.1177/08465371211073158. Online ahead of print. PMID: 35199583

Sushentsev N, McLean MA, Warren AY, Benjamin AJV, Brodie C, Frary A, Gill AB, Jones J, Kaggie JD, Lamb BW, Locke MJ, Miller JL, Mills IG, Priest AN, Robb FJL, Shah N, Schulte RF, Graves MJ, Gnanapragasam VJ, Brindle KM, Barrett T, Gallagher FA. Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer. Nat Commun. 2022 Jan 24;13(1):466. doi: 10.1038/s41467-022-28069-2. PMID: 35075123

Arjun Nathan,  Shivani Shukla, Amil Sinha, Sailantra Sivathasan, Amir Rashid, Joseph Rassam, Sonny       Smart, Keval Patel, Nimish Shah, Benjamin W. Lamb: Immediate post‑operative PDE5i therapy improves early erectile function  outcomes after robot assisted radical prostatectomy (RARP). Journal of Robotic Surgery https://doi.org/10.1007/s11701-021-01198-4. Accepted 15.1.21.

Saiful Miah, Martin J. Connor, Oliver Wiseman, Nimish Shah: Retrograde migration of a vesicoureteric junction calculus: A potential pitfall of the noncontrast limited pelvic computerized tomography; Urology Annals, February 1, 2021, IP: 77.103.9.71

Caglic I, Sushentsev N, Shah N, Warren AY, Lamb BW, Barrett T. Comparison of biparametric versus multiparametric prostate MRI for the detection of extracapsular extension and seminal vesicle invasion in biopsy naïve patients. Eur J Radiol. 2021 Aug;141:109804. doi:10.1016/j.ejrad.2021.109804. Epub 2021 May 27. PMID: 34062473

Peter J. Campbell, Gad Getz, Jan O Korbel et al: Pan-cancer analysis of whole genomes. Nature research. Feb 2020 Nature 578(7793):82-93 DOI:  · 10.1038/s41586-020-1969-6

Tristan Barrett, R Slough, Nikita Sushentsev, Nadeem Shaida, B C Koo, Iztok Cagilik, V. V. Kozlov, Anne Y Warren, Vineetha V. Thankappannair,  C. Pinnock, Nimish Shah, Kasra Saeb-Parsy, Vincent Gnanapragasam, Evis Sala, Christof Kastner: Three-year experience of a dedicated prostate mpMRI pre-biopsy programme and effect on timed cancer diagnostic pathways. July 2019, Clinical Radiology 74(11) DOI: · 10.1016/j.crad.2019.06.004

Memberships

  • British Association of Urological Surgeons
  • General Medical Council
  • British Medical Association

Other posts held

  • Consultant Urological Surgeon, Addenbrookes Hospital, Cambridge

Insurers Mr Nimish Shah works with

Mr Nimish Shah works with the following private medical insurance providers:

  • Aviva Health
  • AXA Health
  • AXA - Global Healthcare
  • Bupa
  • Cigna
  • CS Healthcare
  • Exeter Family Friendly
  • Simplyhealth
  • Vitality Health (Pru Health)
  • WPA

Declaration

Mr Nimish Shah does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Mr Nimish Shah has the following interest in equipment used at this hospital or another Nuffield Health hospital:

Mr Nimish Shah, as a partner of Cambridge Urology Partnership, owns a share in a 100 W Holmium Laser, and associated equipment for undertaking laser prostate surgery (HoLEP), used at the Nuffield Health Cambridge Hospital.

Mr Nimish Shah does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.